Clinical trial condition

MDS

Explore clinical trials studying MDS. Study availability and eligibility vary by location and protocol.

105 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

MDS trial results

Enrolling by Invitation

A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

NCT06664970

Conditions: MDS
Locations: Bing Han Beijing, China

View Trial Details

Not Yet Recruiting

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

NCT07575412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

NCT07387354

Conditions: Bone Marrow Disease, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

NCT07562568

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

NCT07131085

Conditions: AML, MDS
Locations: Not specified

View Trial Details

Not Yet Recruiting

Reduced Intensity Conditioning for MDS

NCT07085156

Conditions: MDS
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT

NCT06765928

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

NCT06594965

Conditions: Anemia, Bone Marrow Disease, Bone Marrow Diseases, +4 more
Locations: Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

NCT05177211

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Neutrophilic Leukemia, +9 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

NCT05829226

Conditions: AML, Adult Recurrent, Disease Attributes, Hematologic Diseases, +10 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

University of California Irvine Medical Center Orange, California, United States

Baptist Health South Florida-Miami Cancer Institute Miami, Florida, United States

Norton Healthcare-Norton Cancer Institute Louisville, Kentucky, United States

View Trial Details

MDS

MDS trial results

Related conditions